New research shows menstrual cycle timing can alter drug effectiveness
Recent studies reveal that fluctuations in estrogen during a woman's menstrual cycle can change how well certain medicines work, including COVID-19 vaccines and experimental Alzheimer’s treatments.
A growing body of evidence indicates that the natural rise and fall of estrogen across the menstrual cycle can significantly affect drug performance. Researchers highlighted that the COVID-19 vaccine caused a modest, temporary lengthening of menstrual cycles and that timing of vaccination—follicular versus luteal phase—altered both side-effect rates and duration of immunity. In a re-analysis of the Alzheimer’s-targeted drug davenutide, women showed higher drug uptake than men, a pattern traced to estrogen-driven changes in brain blood flow and the blood-brain barrier.
Laboratory work with mice confirmed that peak estrogen levels boosted nasal-spray absorption, and a small human trial mirrored these findings. A 2025 review further demonstrated that estrogen can suppress key CYP liver enzymes, potentially slowing the metabolism of drugs such as ibuprofen, caffeine, omeprazole, alprazolam, and sildenafil. Experts argue that overlooking menstrual cycle phases may have masked important variations in treatment outcomes for women.
Why it matters
Understanding cycle-related drug differences can improve dosing and efficacy for half the population.
In this story
